Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial
Abstract Background Status epilepticus (SE) is an emergency condition for which rapid and secured cessation is important. Phenytoin and fosphenytoin, the prodrug of phenytoin with less severe adverse effects, have been recommended as second-line treatments. However, fosphenytoin causes severe advers...
Main Authors: | Kensuke Nakamura, Aiki Marushima, Yuji Takahashi, Akio Kimura, Masahiro Asami, Satoshi Egawa, Junya Kaneko, Yutaka Kondo, Chikara Yonekawa, Eisei Hoshiyama, Takeshi Yamada, Kazushi Maruo, Yoshiaki Inoue, IENE ECT with the LIFE study group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05269-7 |
Similar Items
-
Levetiracetam vs. Fosphenytoin for Second-Line Treatment of Status Epilepticus: Propensity Score Matching Analysis Using a Nationwide Inpatient Database
by: Kensuke Nakamura, et al.
Published: (2020-07-01) -
Levetiracetam versus phenytoin in children with status epilepticus
by: Gowhar Wani, et al.
Published: (2019-01-01) -
Fosphenytoin in Infants and Children
by: J Gordon Millichap
Published: (1998-11-01) -
Emergency treatment with levetiracetam or phenytoin in status epilepticus in children—the EcLiPSE study: study protocol for a randomised controlled trial
by: Mark D. Lyttle, et al.
Published: (2017-06-01) -
Phenytoin versus Levetiracetam for Prevention of Early Posttraumatic Seizures: A Prospective Comparative Study
by: Kairav S. Shah, et al.
Published: (2015-11-01)